Update in Staging Systems

  • P. C. Sogani
  • W. F. WhitmoreJr.
Part of the Clinical Practice in Urology book series (PRACTICE UROLOG)


Aside from purely taxonomic purposes, the staging of prostatic cancer is important to planning mangement, estimating prognosis, characterizing individual patients or groups of patients, and comparing results of various treatments. There is as yet no universally accepted clinical staging classification for prostatic cancer but two systems, the American and the TNM, with various modifications, are widely used (Whitmore 1984).


Prostatic Cancer Seminal Vesicle Pelvic Lymph Node Digital Rectal Examination Pelvic Lymphadenectomy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. American Joint Committee for Cancer Staging and End Results Reporting (1978) Manual for staging of cancer. Whiting Press, New Jersey, pp 119–124Google Scholar
  2. Barzell W, Bean MA, Hilaris BS, Whitmore WF Jr (1977) Prostatic adenocarcinoma: relationship of grade and local extent to the pattern of metastases. J Urol 118: 278–282PubMedGoogle Scholar
  3. Bauer WC, McGavran MH, Carlin MR (1960) Unsuspected carcinoma of the prostate in suprapubic prostatectomy specimens. Cancer 13: 370–378PubMedCrossRefGoogle Scholar
  4. Beahrs OH, Myers MH (eds) (1983) Manual for staging of cancer. JB Lippincott, Philadelphia, pp 159–163Google Scholar
  5. Bergman RT, Turner R, Barnes RW, Hadley HL (1955) Comparative analysis of one thousand consecutive cases of transurethral prostatic resection. J Urol 74: 533–548PubMedGoogle Scholar
  6. Boxer RJ (1977) Adenocarcinoma of the prostate gland. Urol Survey 27: 75–82Google Scholar
  7. Bruce AW, O’Clevieachain F, Morales A, Awad SA (1977) Carcinoma of the prostate: a critical look at staging. J Urol 117: 319–322PubMedGoogle Scholar
  8. Cantrell BB, Deklerk DP, Eggleston JC, Boitnott JK, Walsh PC (1981) Pathological factors that influence prognosis in stage A prostatic cancer: the influence of extent versus grade. J Urol 125: 516–520PubMedGoogle Scholar
  9. Carlton CE Jr, Hudgins PT, Guerriero WG, Scott R Jr (1976) Radiotherapy in the management of stage C carcinoma of the prostate. J Urol 116: 206–210PubMedGoogle Scholar
  10. Catalona WJ (1984) Prostate cancer. Grune & Stratton, Orlando, pp 57-83 Catalona WJ, Scott WW (1978) Carcinoma of the prostate: a review. J Urol 119: 1–8Google Scholar
  11. Denton SE, Choy SH, Valk WL (1965) Occult prostatic carcinoma diagnosed by the step section technique of the surgical specimen. J Urol 93: 296–298PubMedGoogle Scholar
  12. deVere White R, Paulson DF, Glenn JF (1977) The clinical spectrum of prostate cancer. J Urol 117: 323–327Google Scholar
  13. Donohue RE, Pfister RR, Weigel JW, Stonington OG (1977) Pelvic lymphadenectomy in stage A prostatic cancer. Urology 9: 273–275PubMedCrossRefGoogle Scholar
  14. Donohue RE, Fauver HE, Whitesel JA, Pfister RR (1979) Staging prostatic cancer: a different distribution. J Urol 122: 327–329PubMedGoogle Scholar
  15. Donohue RE, Mani JH, Whitesel JA et al. (1982) Pelvic lymph node dissection. Guide to patient management in clinically locally confined adenocarcinoma of prostate. Urology 20: 559–565PubMedCrossRefGoogle Scholar
  16. Fowler JE, Whitmore WF Jr (1981) The incidence and extent of pelvic lymph node metastases in apparently localized prostatic cancer. Cancer 47: 2941–2945PubMedCrossRefGoogle Scholar
  17. Golimbu M, Morales P (1979) Stage A2 prostatic carcinoma. Should staging systems be reclassified? Urology 13: 592–596PubMedCrossRefGoogle Scholar
  18. Golimbu M, Schinella R, Morales P, Kurusu S (1978) Differences in pathological characteristics and prognosis of clinical A2 prostatic cancer from Al and B disease. J Urol 119: 618–622PubMedGoogle Scholar
  19. Hirst AE Jr, Bergman RT (1954) Carcinoma of the prostate in men 80 or more years old. Cancer 7: 136–141PubMedCrossRefGoogle Scholar
  20. Jewett HJ (1975) The present status of radical prostatectomy for stages A and B prostatic cancer. Urol Clin North Am 2: 105–124PubMedGoogle Scholar
  21. Jewett HJ, Bridge RW, Gray GF Jr, Shelley WM (1968) The palpable nodule of prostatic cancer: results 15 years after radical excision. JAMA 203: 403–406PubMedCrossRefGoogle Scholar
  22. McCullough DL (1980) Surgical staging of carcinoma of the prostate. Cancer 45: 1902–1905PubMedGoogle Scholar
  23. McLaughlin A, Saltzstein SL, McCullough DL, Gittes RF (1976) Prostatic carcinoma: incidence and location of unsuspected lymphatic metastases. J Urol 115: 89–94PubMedGoogle Scholar
  24. McMillen SM, Wettlaufer JN (1976) The role of repeat transurethral biopsy in stage A carcinoma of the prostate. J Urol 116: 759–760PubMedGoogle Scholar
  25. Murphy GP. Natrajan N, Pontes JE, Schmitz RL, Smart CR, Schmidt JD, Mettlin C (1982) The natural survey of prostate cancer in the United States by the American College of Surgeons. J Urol 127:928–934PubMedGoogle Scholar
  26. Nicholson TC, Richie JP (1977) Pelvic lymphadenectomy for stage B1 adenocarcinoma of the prostate: justified or not? J Urol 117: 199–201PubMedGoogle Scholar
  27. Parfitt HE Jr, Smith JA Jr, Seaman JP, Middleton RG (1983) Surgical treatment of stage A2 prostatic carcinoma: significance of tumor grade and extent. J Urol 129: 763–765PubMedGoogle Scholar
  28. Prout GR Jr, Heaney JA, Griffin PP, Daly JJ, Shipley WU (1980) Nodal involvement: a prognostic indicator in patients with prostatic carcinoma. J Urol 124: 226–231PubMedGoogle Scholar
  29. Rich AR (1935) On the frequency of occurrence of occult carcinoma of the prostate. J Urol 33: 215–223Google Scholar
  30. Sheldon CA, Williams RD, Fraley EE (1980) Incidental carcinoma of the prostate: a review of the literature and critical reappraisal of classification. J Urol 124: 626–631PubMedGoogle Scholar
  31. Smith GG, Woodruff LM (1950) The development of cancer of the prostate after subtotal prostatectomy. J Urol 63: 1077–1080PubMedGoogle Scholar
  32. Varkarakis M, Casto JE, Azzopardi JG (1970) Prognosis of stage I carcinoma of the prostate. Proc R Soc Med 63: 91–95PubMedGoogle Scholar
  33. Veterans Administration Cooperative Urological Research Group (1967) Treatment and survival of patients with cancer of the prostate. Surg Gynecol Obstet 124: 1011–1017Google Scholar
  34. Wallace DM, Chisholm GD, Hendry WF (1975) TNM classification for urological tumors - 1974. Br J Urol 47: 1–712PubMedCrossRefGoogle Scholar
  35. Whitesel JA, Donohue RE, Mani JH et al. (1984) Acid phosphatase: its influence in the management of carcinoma of the prostate. J Urol 131: 70–72PubMedGoogle Scholar
  36. Whitmore WF Jr (1956) Hormone therapy in prostatic cancer. Am J Med 21: 697–713PubMedCrossRefGoogle Scholar
  37. Whitmore WF Jr (1984) Natural history and staging of prostate cancer. Urol Clin North Am 11: 205–220PubMedGoogle Scholar
  38. Whitmore WF Jr (1980) Interstitial radiation therapy for carcinoma of the prostate. Prostate 1: 157–168PubMedCrossRefGoogle Scholar
  39. Wilson CA, Dahl DS, Middleton G (1977) Pelvic lymphadenectomy for staging of apparently localized prostatic cancer. J Urol 117: 197–198PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • P. C. Sogani
  • W. F. WhitmoreJr.

There are no affiliations available

Personalised recommendations